MASIMO CORP - 11 Aug 2023 Form 4/A - Amendment Insider Report for Neuraxis, INC (NRXS)

Role: 10%+ Owner
Signature: /s/ Micah Young, Attorney-In-Fact
Issuer symbol: NRXS
Transactions as of: 11 Aug 2023
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 11 Aug 2023, 19:42:34 UTC
Date Of Original Report: 10 Aug 2023
Previous filing: 10 Aug 2023
Next filing: 03 Jul 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NRXS	Common Stock	Conversion of derivative security		+531,548			531,548	11 Aug 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NRXS	Series A Preferred Stock	Conversion of derivative security	$0	-265,774	-100%	$0.000000^*	0	11 Aug 2023	Common Stock	531,548		Direct	F1
transaction	NRXS	Pre-Funded Warrant, Series A Preferred Stock (Right to Buy)	Conversion of derivative security	$0	-144,890	-100%	$0.000000^*	0	11 Aug 2023	Series A Preferred Stock	144,890	$0.000100	Direct	F2
transaction	NRXS	Pre-Funded Warrant, Common Stock (Right to Buy)	Conversion of derivative security	$0	+289,779		$0.000000	289,779	11 Aug 2023	Common Stock	289,779	$0.000500	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each one share of Series A Preferred Stock converted automatically upon the Issuer's consummation of an initial public offering into two shares of the Issuer's Common Stock. The Series A Preferred Stock had no expiration date.
F2	The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.00005 per share of the Issuer's Common Stock.